Sustained release formulation of nalbuphine

US9351938B2 · kind B2 · utility

Assignee

• ENDO PHARMACEUTICALS INC. · US

Inventors

• Anand R. Baichwal · Wappingers Falls, US
• Philip A. Goliber · Lasne, BE
• Anthony E. Carpanzano · New Milford, US
• Thomas Sciascia · Belmont, US
• Donald Diehl, II · New Fairfield, US
• Brian Vogler · North White Plains, US
• David Verbel · New York, US
• Stanley Au · Bethesda, US

Key dates

• Filing date: May 29, 2014
• Grant date: May 31, 2016
• Expiry date: May 29, 2034

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P25/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.